Back to Search Start Over

Outcomes of staged conjunctival flap and corneal transplantation for infectious keratitis resistant to medical treatment.

Authors :
Kilian R
Pellegrini M
Yu AC
de Ruvo V
Salgari N
Busin M
Source :
The British journal of ophthalmology [Br J Ophthalmol] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Background/aims: To explore the outcomes of conjunctival flap (CF) followed by keratoplasty in patients with severe infectious keratitis (IK) unresponsive to medical treatment.<br />Methods: This is a retrospective monocentric study including 29 eyes of 29 patients with IK resistant to antibiotic treatment associated with stromal ulcer deepening to ≥50% of corneal thickness. All eyes underwent Gundersen's CF procedure and penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK) or mushroom keratoplasty (MK), at least 4 months thereafter. Outcome measures included corrected distance visual acuity (CDVA), endothelial cell count (ECC), graft survival and complications.<br />Results: IK healed in all eyes following CF. The mean time interval between CF and keratoplasty was 16.3±16.1 months. 55% of patients underwent PK, 35% MK and 10% DALK. Mean follow-up duration was 39.6±34.3 months. At the last available follow-up, a CDVA≥20/200 was obtained in 50%, 33.3% and 70% of cases, respectively after PK, DALK and MK. Mean annual endothelial cell loss was 24.5% following PK and 10.7% following MK. Overall, graft failure occurred in 75% of cases after PK, 100% after DALK and 20% after MK. The most frequent complications were endothelial decompensation without immunological rejection (34.5%, after 31.1±25.1 months) and graft rejection (17.2%, after 10.2±7.9 months, all in the PK group).<br />Conclusion: CF surgery followed by staged keratoplasty represents an alternative therapeutic approach to avoid high-risk keratoplasty 'a chaud' in cases of severe IK.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1468-2079
Database :
MEDLINE
Journal :
The British journal of ophthalmology
Publication Type :
Academic Journal
Accession number :
39643279
Full Text :
https://doi.org/10.1136/bjo-2024-326225